A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world’s first commercialization of Nobel Prize-winning stem cell research.
TOKYO/OSAKA -- Japan on Thursday moved a step closer to approving the sale of two regenerative medicine products using induced pluripotent stem cells, marking the world's first iPS cell-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results